Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17424785 | 1.00 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL13013091 | 0.96 | — | — | |
| SCHEMBL10011775 | 0.96 | — | — | |
| SCHEMBL24930590 | 0.96 | — | — | |
| SCHEMBL10601537 | 0.92 | MEN1 (0.31) | MEN1KMT2ATDP1 | |
| SCHEMBL18477578 | 0.85 | — | — | |
| SCHEMBL16473081 | 0.83 | — | — | |
| SCHEMBL7055080 | 0.81 | — | — | |
| SCHEMBL3224252 | 0.78 | — | — | |
| SCHEMBL3214902 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6280704-B1 | MICROBUBBLES OSMOTICALLY STABILIZED WITH PERFLUOROCARBON GAS | ALLIANCE PHARMACEUTICAL CORP. | 2001-08-28 | — | — | US | claimed |
| US-5300468-A | Carbonaceous adsorbent regeneration and halocarbon displacement by hydrocarbon gases | ASSOCIATED UNIVERSITIES, INC. (US) | 1994-04-05 | — | — | US | claimed |
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20210347757-A1 | HETEROCYCLIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-11-11 | — | — | US | disclosed |
| US-11124492-B2 | Heterocyclic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-09-21 | — | — | US | disclosed |
| US-20210230137-A1 | PYRAZINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-07-29 | — | — | US | disclosed |
| US-11001567-B2 | Pyrazine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-05-11 | — | — | US | disclosed |
| US-10645929-B2 | Pyrimidine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-12 | — | — | US | disclosed |
| US-20200109128-A1 | PYRAZINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-04-09 | — | — | US | disclosed |
| US-10577343-B2 | Pyrazine compound and arthropod pest control agent containing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-03-03 | — | — | US | disclosed |
| US-10392699-B2 | Method for manufacturing structure having recessed pattern, resin composition, method for forming electroconductive film, electronic circuit, and electronic device | JSR CORPORATION (JP) | 2019-08-27 | — | — | US | disclosed |
| US-8546063-B2 | Organic solvent development or multiple development pattern-forming method using electron beams or EUV rays | FUJIFILM CORPORATION (JP) | 2013-10-01 | — | — | US | disclosed |
| US-8404756-B2 | Foamable fluoropolymer composition | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-26 | — | — | US | disclosed |
| US-20120199377-A1 | FOAMABLE FLUOROPOLYMER COMPOSITION | E. I. DU PONT DE NEMOURS AND .COMPANY (US) | 2012-08-09 | — | — | US | disclosed |
| US-8178592-B2 | Foamable fluoropolymer composition | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-15 | — | — | US | disclosed |
| US-20100288533-A1 | Foamable Fluoropolymer Composition | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-18 | — | — | US | disclosed |
| US-7638709-B2 | Fluoropolymer wire insulation | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-12-29 | — | — | US | disclosed |
| US-20080283271-A1 | Fluoropolymer Wire Insulation | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-11-20 | — | — | US | disclosed |
| US-7410011-B2 | Method to determine the concentration of deuterium oxide in a subterranean formation | CORE LABORATORIES LP (US) | 2008-08-12 | — | — | US | disclosed |
| US-20070215385-A1 | Method to determine the concentration of deuterium oxide in a subterranean formation | CORE LABORATORIES LP (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230189636-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | EMC1, EMC2, EPCAM | MEN1 2836/4885KMT2A 845/4885TDP1 3083/4885 |
| US-20210230137-A1 | PYRAZINE COMPOUND | PPOX, NOX5, NISCH | MEN1 2337/4885KMT2A 2339/4885TDP1 4655/4885 |
| US-10577343-B2 | Pyrazine compound and arthropod pest control agent containing same | PPOX, NOX5, NISCH | MEN1 2559/4885KMT2A 2007/4885TDP1 4579/4885 |
| US-20210347757-A1 | HETEROCYCLIC COMPOUND | NR4A2, NR4A1, NR2C2 | MEN1 2604/4885KMT2A 3867/4885TDP1 4245/4885 |
| US-11001567-B2 | Pyrazine compound | PPOX, NOX5, NISCH | MEN1 2337/4885KMT2A 2339/4885TDP1 4655/4885 |
| US-11124492-B2 | Heterocyclic compound | NR4A2, NR4A1, NR2C2 | MEN1 2604/4885KMT2A 3867/4885TDP1 4245/4885 |
| US-20200109128-A1 | PYRAZINE COMPOUND | PPOX, NOX5, NISCH | MEN1 2337/4885KMT2A 2339/4885TDP1 4655/4885 |
| US-10645929-B2 | Pyrimidine compound | C5, PRPF4, RRM2 | MEN1 1996/4885KMT2A 2202/4885TDP1 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.